| |
Group
|
Study initiation(months)
|
Between-Subjects Effects
|
|---|
|
0
|
3
|
6
|
F
|
P
|
|---|
|
CD4%
|
Control (n = 4)
|
39.14 ± 12.06
|
47.35 ± 7.59
|
47.93 ± 9.56
|
5.739
|
0.028*
|
|
LTNP (n = 4)
|
31.41 ± 8.04
|
31.46 ± 9.23
|
31.60 ± 8.89
|
|
Progressors (n = 4)
|
21.54 ± 6.31
|
27.61 ± 5.45
|
26.40 ± 5.10
|
|
CD8%
|
Control (n = 4)
|
25.29 ± 6.07
|
31.82 ± 4.27
|
34.41 ± 1.52
|
0.486
|
0.632
|
|
LTNP (n = 4)
|
32.27 ± 3.03
|
39.24 ± 3.65
|
37.79 ± 7.70
|
|
Progressors (n = 4)
|
32.12 ± 12.36
|
33.07 ± 10.50
|
35.08 ± 13.27
|
|
CD4/CD8
|
Control (n = 4)
|
1.56±0.44
|
1.49 ± 0.10
|
1.39 ± 0.26
|
21.093
|
0.001**
|
|
LTNP (n = 4)
|
0.97 ± 0.21
|
0.79 ± 0. 19
|
0.83 ± 0.11
|
|
Progressors (n = 4)
|
0.69 ± 0.08
|
0.86 ± 0. 11
|
0.80 ± 0.17
|
- *,P < 0.05 in the Analysis of variance (ANOVA) for Repeated Measures
- **,P < 0.01 in the Analysis of variance (ANOVA) for Repeated Measures
